Pharmchem Stock Probability of Future Pink Sheet Price Finishing Under 3.1
| PCHM Stock | USD 3.10 0.05 1.64% |
PharmChem |
PharmChem Target Price Odds to finish below 3.1
The tendency of PharmChem Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 3.10 | 90 days | 3.10 | nearly 4.89 |
Based on a normal probability distribution, the odds of PharmChem to move below current price in 90 days from now is nearly 4.89 (This PharmChem probability density function shows the probability of PharmChem Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days PharmChem has a beta of 0.37 indicating as returns on the market go up, PharmChem average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding PharmChem will be expected to be much smaller as well. Additionally PharmChem has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. PharmChem Price Density |
| Price |
Predictive Modules for PharmChem
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PharmChem. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.PharmChem Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. PharmChem is not an exception. The market had few large corrections towards the PharmChem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PharmChem, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PharmChem within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.18 | |
β | Beta against Dow Jones | 0.37 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | -0.06 |
PharmChem Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PharmChem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PharmChem can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PharmChem generated a negative expected return over the last 90 days | |
| PharmChem has high historical volatility and very poor performance | |
| The company has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist PharmChem until it has trouble settling it off, either with new capital or with free cash flow. So, PharmChem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PharmChem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PharmChem to invest in growth at high rates of return. When we think about PharmChem's use of debt, we should always consider it together with cash and equity. | |
| PharmChem reported the previous year's revenue of 26.45 M. Net Loss for the year was (2.15 M) with profit before overhead, payroll, taxes, and interest of 5.86 M. |
PharmChem Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PharmChem Pink Sheet often depends not only on the future outlook of the current and potential PharmChem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PharmChem's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Long Term Debt | 1.9 M | |
| Forward Annual Dividend Rate | 0.12 |
PharmChem Technical Analysis
PharmChem's future price can be derived by breaking down and analyzing its technical indicators over time. PharmChem Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PharmChem. In general, you should focus on analyzing PharmChem Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
PharmChem Predictive Forecast Models
PharmChem's time-series forecasting models is one of many PharmChem's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PharmChem's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about PharmChem
Checking the ongoing alerts about PharmChem for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PharmChem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| PharmChem generated a negative expected return over the last 90 days | |
| PharmChem has high historical volatility and very poor performance | |
| The company has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist PharmChem until it has trouble settling it off, either with new capital or with free cash flow. So, PharmChem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PharmChem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PharmChem to invest in growth at high rates of return. When we think about PharmChem's use of debt, we should always consider it together with cash and equity. | |
| PharmChem reported the previous year's revenue of 26.45 M. Net Loss for the year was (2.15 M) with profit before overhead, payroll, taxes, and interest of 5.86 M. |
Other Information on Investing in PharmChem Pink Sheet
PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.